CAAS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

CAAS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.34M	Buy	+4,700	New	+$2.55M	0.25%	92
2024 Q2	–	Sell	-4,800	Closed	-$2.79M	–	495
2024 Q1	$2.79M	Sell	4,800 -400	-8%	-$224K	0.2%	126
2023 Q4	$2.76M	Buy	+5,200	New	+$2.52M	0.29%	86
2023 Q3	–	Sell	-900	Closed	-$469K	–	811
2023 Q2	$469K	Sell	900 -5,600	-86%	-$3.02M	0.03%	393
2023 Q1	$3.75M	Sell	6,500 -3,500	-35%	-$1.97M	0.2%	124
2022 Q4	$5.51M	Buy	10,000 +7,900	+376%	+$4.19M	0.33%	94
2022 Q3	$1.07M	Hold	2,100	–	–	0.05%	360
2022 Q2	$1.14M	Hold	2,100	–	–	0.06%	350
2022 Q1	$1.24M	Sell	2,100 -11,100	-84%	-$6.38M	0.05%	274
2021 Q4	$8.81M	Hold	13,200	–	–	0.21%	122
2021 Q3	$7.54M	Hold	13,200	–	–	0.15%	146
2021 Q2	$6.66M	Sell	13,200 -9,800	-43%	-$4.62M	0.11%	196
2021 Q1	$10.5M	Buy	+23,000	New	+$11M	0.11%	206

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CAAS Capital Management's TMO Position: Q1 2025 in Review

CAAS Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2025: 1,660 shares worth $826K. The stake represents 0.09% of the portfolio and ranks #208 among its holdings. This is a return to the name: CAAS Capital Management previously reported a position in TMO as recently as Q4 2022.

CAAS Capital Management first reported a position in TMO in Q1 2021 and has held it in 5 quarters since. The position peaked at $2.2M in Q1 2021. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

CAAS Capital Management held 1,660 shares of Thermo Fisher Scientific worth $826K as of Q1 2025.
Thermo Fisher Scientific was a new CAAS Capital Management position in Q1 2025.
Thermo Fisher Scientific made up 0.09% of CAAS Capital Management's portfolio in Q1 2025, its #208 holding.
CAAS Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 5 quarters since.
CAAS Capital Management's Thermo Fisher Scientific position peaked at $2.2M in Q1 2021.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.